Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10%

G. Kontochristopoulos,V. Markantoni,E. Agiasofitou,E. Platsidaki,A. Kouris,A. Campanati,A.M. Offidani,D. Rigopoulos,S. Gregoriou
DOI: https://doi.org/10.1111/jdv.17297
2021-05-06
Journal of the European Academy of Dermatology and Venereology
Abstract:<p>Primary focal hyperhidrosis is a common disorder with a significant impact on quality of life<sup>1</sup>. Topical anticholinergics are an emerging therapeutic class in the treatment of focal hyperhidrosis. Glycopyrronium tosylate 3.75% cloth was FDA approved for the treatment of axillary hyperhidrosis in adults and children aged 9 years or older in 2018.</p>
dermatology
What problem does this paper attempt to address?